4D Molecular Therapeutics stock price
4D 멀레큘러 테라퓨틱스NASDAQ:FDMT · Nasdaq · HealthcareToday's signals · No active technical signal.
Signal details →4D Molecular Therapeutics last closed at $13.67 (-1.23%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -5.4×. Its overall grade ranks 432 of 739 stocks in Healthcare.
About this company
4D Molecular Therapeutics last closed at $13.67 (-1.23%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B- · 432/739
Valuation grade B
Related stocks
- AbbVieCustomer
안과 유전자치료 후보의 파트너/상업화 고객 가능성이 있는 대형 제약사
- BayerCustomer
안과·유전자치료 영역에서 협력/라이선스 파트너로 연결되는 대형 제약사
- NovartisCompetitor
망막·안과 질환 유전자치료에서 경쟁하는 글로벌 대형 제약사
About 4D Molecular Therapeutics
- What technical signals does 4D Molecular Therapeutics (FDMT) have?
- 4D Molecular Therapeutics current technical signals: no active technical signal.
- Is 4D Molecular Therapeutics a cup-and-handle pattern?
- No. 4D Molecular Therapeutics has no valid Cup signal right now.
- What published figures are available for 4D Molecular Therapeutics?
- Market cap: $781.04M. Trailing 12 months PER: -5.4×. Latest quarter PBR: 2.36×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about 4D Molecular Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.